Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis–HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week

BACKGROUND: To evaluate the pharmacokinetic of plasma lopinavir (LPV) and ritonavir (RTV) when co-administered with three times weekly (TPW) rifabutin (RBT) at a dose of either 150 or 300 mg in African tuberculosis (TB) and HIV co-infected adult patients. METHODS: This is a pharmacokinetic study con...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouedraogo, Henri Gautier, Matteelli, Alberto, Sulis, Giorgia, Compaore, Tegwinde Rebeca, Diagbouga, Serge, Tiendrebeogo, Simon, Roggi, Alberto, Cisse, Kadari, Giorgetti, Pier Francesco, Villani, Paola, Sangare, Lassana, Simpore, Jacques, Regazzi, Mario, Kouanda, Seni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974970/
https://www.ncbi.nlm.nih.gov/pubmed/31969147
http://dx.doi.org/10.1186/s12941-020-0345-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974970/
https://www.ncbi.nlm.nih.gov/pubmed/31969147
http://dx.doi.org/10.1186/s12941-020-0345-6

Ejemplares similares